Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis

Journal Article Accepted manuscript Successful switching from mepolizumab to dupilumab in a patient with EGPA in remission phase and persistent nasal polyposis Get access Marco Caminati, Marco Caminati Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy Corresponding Author: Marco Caminati, Department of Medicine, University of Verona and Verona University Hospital, Piazzale Scuro 10, 37134 Verona, Italy, Tel: +39 045 8123526, Fax: +39 045 8122048, E-mail: marco.caminati@univr.it https://orcid.org/0000-0001-7383-1487 Search for other works by this author on: Oxford Academic PubMed Google Scholar Elena Scarpieri, Elena Scarpieri School of specialization in Allergy and Clinical Immunology, Department of Medicine, University of Verona, Verona, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Matteo Maule, Matteo Maule Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Patrick Pinter, Patrick Pinter Unit of Otolaryngology, Head and Neck Department, University of Verona, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Michele Schiappoli, Michele Schiappoli Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Rachele Vaia, Rachele Vaia Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Gianenrico Senna Gianenrico Senna Department of Medicine, University of Verona and Verona University Hospital, Verona, ItalyAsthma Center and Allergy Unit, Verona University Hospital, Verona, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, kead479, https://doi.org/10.1093/rheumatology/kead479 Published: 11 September 2023 Article history Received: 31 May 2023 Revision received: 22 August 2023 Accepted: 29 August 2023 Published: 11 September 2023